FPT-025

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFPT-025
Drug Alias NameIL-34 (FivePrime)FPT-025
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionExtracellular-signal-regulated kinase1 stimulantsExtracellular-signal-regulated kinase 2 stimulants
TargetsExtracellular-signal-regulated kinase1Extracellular-signal-regulated kinase 2
Therapy Area/IndicationsInflammationNeoplasmsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFive Prime Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFive Prime Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasmsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A